Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Stifel Nicolaus Healthcare Conference on September 5, 2012 at 1:30 p.m. ET in Boston.
In addition, Infinity will be presenting at the BioCentury Newsmakers Conference on September 7, 2012 at 2:30 p.m. ET in New York City.
A live webcast of each of Infinity's presentations will be accessible in the Investors/Media section of the company's website at www.infi.com, and will be available for 30 days following each event.
About Infinity Pharmaceuticals, Inc.Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for diseases with significant unmet need. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs focused on the inhibition of phosphoinositide-3-kinase, heat shock protein 90 and fatty acid amide hydrolase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company’s website at www.infi.com.